A股異動丨愛美客績後連續第3日上升
愛美客(300896.SZ)盤中大升近7%至319.78元,為連續第三日上升。愛美客1月5日晚發佈業績預吿,預計23年歸母淨利潤18.1-19億元,同比增長43-50%;其中,預計23Q4實現歸母淨利潤3.92~4.82億元,同比增長44%~78%。首創證券研報指其全年業績符合預期,Q4為淡季,業績區間中值的環比變動較Q3有所修復。當前愛美客現有產品仍處於放量增長期,再生針劑產品風口正起,看好雙生天使組合未來表現,在研產品儲備豐富,多業務佈局提振業績持續增長信心,內生外延成長動力充足,看好公司業績成長前景。維持公司“買入”評級。光大證券稱,公司全年業績基本符合預期,投資價值逐漸凸顯。公司作為醫美龍頭企業,當前估值水平較低,維持“買入”評級。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.